Corient Private Wealth
AMRX icon

Corient Private Wealth’s Amneal Pharmaceuticals AMRX Stock Holding History

Corient Private Wealth’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.61M Buy
150,698
+139,568
+1,254% +$1.91M ﹤0.01% 1222
2026
Q1 		$138K Sell
11,130
-2,698
-20% -$36.2K ﹤0.01% 2635
2025
Q4 		$174K Buy
+13,828
New +$158K ﹤0.01% 2453

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Corient Private Wealth's AMRX Position: Q2 2026 in Review

Corient Private Wealth increased its Amneal Pharmaceuticals (AMRX) stake by 1,254% in Q2 2026, buying an estimated $1.91M and bringing the position to 150,698 shares worth $2.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1222.

Corient Private Wealth first reported a position in AMRX in Q4 2025 and has held it in 3 quarters since. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Corient Private Wealth held 150,698 shares of Amneal Pharmaceuticals worth $2.61M as of Q2 2026.
  • Corient Private Wealth bought 139,568 Amneal Pharmaceuticals shares in Q2 2026, an estimated $1.91M.
  • Amneal Pharmaceuticals made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1222 holding.
  • Corient Private Wealth first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.